Prescription drug rebates from drugmakers to commercial health plans are steadily increasing, a study published in JAMA Health Forum shows.
Why it matters: This is all part of a system in which drugmakers negotiate to get their product on the formularies of middlemen known as pharmacy benefit managers and health plans.
As COVID-19 began to spread in the U.S. in March 2020, Trump administration officials estimated 100,000 to 200,000 Americans might die. A worst-case scenario, they said, meant between 1.6 million and 2.2 million might perish. The figures felt staggeringly high.
Two years later, the U.S. has reached 1 million deaths even as COVID has faded from the headlines.
Most people who support upholding Roe v. Wade view its possible overturn as a danger to women and think that development would put other rights in jeopardy, a CBS News poll out Sunday indicates.
The big picture: The poll comes after the leak Monday of a draft opinion that signaled the U.S. Supreme Court is prepared to overturn the landmark abortion case.
U.S., Food and Drug Administration commissioner Robert Califf told CNN on Saturday evening "almost no one" in the U.S. should be dying from COVID-19, but misinformation was impacting the death toll.
By the numbers: Nearly 998,000 people have died of COVID in the U.S. since the pandemic began as of Sunday night, according to data from Johns Hopkins University.
